Xenon Pharmaceuticals Inc.
Solid state crystalline forms of a selective potassium channel modulator
Last updated:
Abstract:
The present disclosure provides solid state forms of a selective potassium channel modulator and pharmaceutical compositions comprising the solid state crystalline forms and pharmaceutically acceptable excipients, and methods for preparing and using the solid state forms and the pharmaceutical compositions thereof.
Status:
Grant
Type:
Utility
Filling date:
13 Oct 2020
Issue date:
17 Aug 2021